ArticleClinical kidney journal2025
Incidence of cancer in people with CKD not requiring kidney replacement therapy: a systematic review and meta-analysis.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Onco-nephrology in kidney transplant recipients: challenges and evolving strategies.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: Cancer incidence in people with chronic kidney disease (CKD) who do not require kidney replacement therapy remains inadequately characterized. This systematic review aimed to establish whether there is an elevated incidence of cancer in people with CKD. Methods: A systematic search of three online bibliographic databases until 17 January 2023 identified studies reporting cancer incidence in CKD cohorts (PROSPERO CRD42022359690). Meta-analyses using inverse variance method compared incidence rates in individuals with low estimated glomerular filtration rate (eGFR) (<60 mL/min/1.73 m Results: In 27 studies (5 519 778 people with CKD), from 10 countries spanning 2009-2022, incidence rates of cancer were associated with worse CKD severity. Incidence rate ratio (IRR) comparing people with an eGFR <60 mL/min/1.73 m Conclusion: Individuals with CKD have an elevated incidence of cancer, with increasing age contributing to this association. These findings emphasize the importance of investigating whether CKD independently elevates cancer risk, building evidence for tailored cancer screening into CKD patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.